Limited Budgets Drive Refurbished Medical Imaging Equipment Market
|
By HospiMedica International staff writers Posted on 09 Dec 2013 |
Increasing global acceptance of refurbished equipment due to public sector budgetary constraints is encouraging the uptake of refurbished medical imaging equipment in the private sector as well. These are the latest findings of Frost & Sullivan (Frost, Mountain View, CA, USA), an international market research firm.
The Eurozone economic slowdown has made it tough for private hospitals, particularly in Southern Europe, to procure new imaging modalities. Streamlined budgets and escalating number of medical procedures, along with the need to spend less on technologies while gaining the maximum benefit from them, has sustained demand in private hospitals for refurbished equipment across most imaging departments, including nuclear medicine, mammography, and minimally invasive surgeries (MIS).
“Growth of the private healthcare sector has increased the uptake of high-quality imaging modalities, as private hospitals focus strongly on returns on investment,” said Frost healthcare research analyst Raghuraman Madanagopal, BSc. “Refurbished medical imaging equipment provides these hospitals with an opportunity to stay ahead of competitors by conducting more advanced procedures at a lower cost.”
However, the market does present several challenges. For example, reimbursement laws across some European regions, such as France, compel reimbursement to be cut by half if the equipment is older than five years, forcing some hospitals to purchase new equipment. Moreover, regulations in certain countries such as Romania and Bulgaria restrict hospitals from purchasing old equipment using state funded loans. Because almost all public hospitals are covered by the state, they opt for new systems over refurbished models.
“Government regulations that have restricted the purchase of used equipment in some regions are expected to ease following the rapid acceptance of refurbished systems globally,” added Mr. Madanagopal. “With governments relaxing their regulations, the scope for these systems in the public sector will grow.”
According to Frost & Sullivan, the European refurbished medical imaging equipment market earned revenue of USD 417.6 million in 2012, and is estimated to reach USD 582.3 million in 2019.
Related Links:
Frost & Sullivan
The Eurozone economic slowdown has made it tough for private hospitals, particularly in Southern Europe, to procure new imaging modalities. Streamlined budgets and escalating number of medical procedures, along with the need to spend less on technologies while gaining the maximum benefit from them, has sustained demand in private hospitals for refurbished equipment across most imaging departments, including nuclear medicine, mammography, and minimally invasive surgeries (MIS).
“Growth of the private healthcare sector has increased the uptake of high-quality imaging modalities, as private hospitals focus strongly on returns on investment,” said Frost healthcare research analyst Raghuraman Madanagopal, BSc. “Refurbished medical imaging equipment provides these hospitals with an opportunity to stay ahead of competitors by conducting more advanced procedures at a lower cost.”
However, the market does present several challenges. For example, reimbursement laws across some European regions, such as France, compel reimbursement to be cut by half if the equipment is older than five years, forcing some hospitals to purchase new equipment. Moreover, regulations in certain countries such as Romania and Bulgaria restrict hospitals from purchasing old equipment using state funded loans. Because almost all public hospitals are covered by the state, they opt for new systems over refurbished models.
“Government regulations that have restricted the purchase of used equipment in some regions are expected to ease following the rapid acceptance of refurbished systems globally,” added Mr. Madanagopal. “With governments relaxing their regulations, the scope for these systems in the public sector will grow.”
According to Frost & Sullivan, the European refurbished medical imaging equipment market earned revenue of USD 417.6 million in 2012, and is estimated to reach USD 582.3 million in 2019.
Related Links:
Frost & Sullivan
Latest Business News
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreCritical Care
view channel
Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
Hospitalizations for heart failure with preserved ejection fraction (HFpEF) remain common because lung congestion often worsens before symptoms prompt treatment changes. Missed early decompensation... Read more
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read moreSurgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more







